Symbol
RSLS on Nasdaq
Investment type
Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned
200,000 shares
Security Ownership %
5.7%

Ayrton Capital LLC ownership in ReShape Lifesciences Inc. Common Stock, par value $0.001 per share (RSLS)

14 May 2025 - Ayrton Capital LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 200,000 shares of ReShape Lifesciences Inc. Common Stock, par value $0.001 per share (RSLS). This represents 5.7% ownership of the company. This is the first filing by Ayrton Capital LLC disclosing ownership of ReShape Lifesciences Inc. Common Stock, par value $0.001 per share (RSLS).